8 years ago

Nemaura Pharma Secures Up To £5M in Funding

  • Nemaura Pharma, a UK-based biotech company, raised up to £5m in funding from unnamed private investors to accelerate commercial research and development of clinical programs.

      • ProblemLife Sciences

      "Improving control over drug release and absorption, improving stability performance, and either partially or completely eliminating the cold storage requirements for vaccines and biologics."

      Solution

      "Nemaura Pharma's solid dose delivery device, the Micro-Patch™, which deposits the drug under the outer layer of the skin using a metal needle that retracts completely, minimizing the risk of stick injuries."

      Covered on